Compass reports Q1 2026 results with $466 million cash position

Compass Pathways plc (CMPS) — Compass Pathways reported first-quarter 2026 results, posting a loss of roughly $0.30 per share and cash and equivalents of about $466 million against $50.5 million of debt as of March 31.

Management reaffirmed that its cash position funds operations into 2028. The update followed the FDA's grant of rolling review and a National Priority Voucher for COMP360, keeping the company on track toward a Q4 2026 NDA submission.

Source: businesswire.com

For the rest of that week's sector news, read our week in review.